Dynamic evolution of tricuspid regurgitation during hospitalization in patients with acute decompensated heart failure.

IF 16.9 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Eugenio Zocca, Daniele Cocianni, Davide Barbisan, Maria Perotto, Stefano Contessi, Jacopo Giulio Rizzi, Giulio Savonitto, Enrico Brollo, Elisa Soranzo, Antonio De Luca, Marco Merlo, Gianfranco Sinagra, Davide Stolfo
{"title":"Dynamic evolution of tricuspid regurgitation during hospitalization in patients with acute decompensated heart failure.","authors":"Eugenio Zocca, Daniele Cocianni, Davide Barbisan, Maria Perotto, Stefano Contessi, Jacopo Giulio Rizzi, Giulio Savonitto, Enrico Brollo, Elisa Soranzo, Antonio De Luca, Marco Merlo, Gianfranco Sinagra, Davide Stolfo","doi":"10.1002/ejhf.3433","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Secondary tricuspid regurgitation (TR) is associated with poor prognosis in acute decompensated heart failure (ADHF). However, its dynamic evolution in response to volume status and treatment has never been previously investigated. In this study, we sought to explore the in-hospital evolution of TR in ADHF patients and to assess its prognostic implications.</p><p><strong>Methods and results: </strong>We retrospectively enrolled patients admitted for ADHF with ≥2 in-hospital echocardiographic evaluations of TR. Patients were categorized, according to TR evolution, into persistent moderate-severe TR, improved TR (from moderate-severe to trivial-mild) and persistent trivial-mild TR. The primary endpoint was a composite of 5-year all-cause mortality and heart failure hospitalization (HFH). A total of 1054 patients were included. Of 318 patients (30%) with moderate-severe TR at admission, 49% improved TR severity and showed better trends of decongestion, whereas those who maintained persistent moderate-severe TR had characteristics of more severe heart failure at admission and discharge. Atrial fibrillation, previous heart failure and higher dosage of loop diuretics before admission were associated with a lower probability of improved TR. After adjustment, improved TR was associated with lower risk of 5-year all-cause mortality/HFH compared with persistent moderate-severe TR (hazard ratio [HR] 0.524, p = 0.008) and no different from persistent trivial-mild TR (HR 0.878, p = 0.575). Results were consistent across all subgroups of in-hospital variation of mitral regurgitation.</p><p><strong>Conclusion: </strong>Among ADHF patients with moderate-severe TR at admission, 49% had an in-hospital improvement in TR severity, which was associated with a reduction in risk of 5-year all-cause mortality and morbidity outcomes.</p>","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":" ","pages":""},"PeriodicalIF":16.9000,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ejhf.3433","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Secondary tricuspid regurgitation (TR) is associated with poor prognosis in acute decompensated heart failure (ADHF). However, its dynamic evolution in response to volume status and treatment has never been previously investigated. In this study, we sought to explore the in-hospital evolution of TR in ADHF patients and to assess its prognostic implications.

Methods and results: We retrospectively enrolled patients admitted for ADHF with ≥2 in-hospital echocardiographic evaluations of TR. Patients were categorized, according to TR evolution, into persistent moderate-severe TR, improved TR (from moderate-severe to trivial-mild) and persistent trivial-mild TR. The primary endpoint was a composite of 5-year all-cause mortality and heart failure hospitalization (HFH). A total of 1054 patients were included. Of 318 patients (30%) with moderate-severe TR at admission, 49% improved TR severity and showed better trends of decongestion, whereas those who maintained persistent moderate-severe TR had characteristics of more severe heart failure at admission and discharge. Atrial fibrillation, previous heart failure and higher dosage of loop diuretics before admission were associated with a lower probability of improved TR. After adjustment, improved TR was associated with lower risk of 5-year all-cause mortality/HFH compared with persistent moderate-severe TR (hazard ratio [HR] 0.524, p = 0.008) and no different from persistent trivial-mild TR (HR 0.878, p = 0.575). Results were consistent across all subgroups of in-hospital variation of mitral regurgitation.

Conclusion: Among ADHF patients with moderate-severe TR at admission, 49% had an in-hospital improvement in TR severity, which was associated with a reduction in risk of 5-year all-cause mortality and morbidity outcomes.

Abstract Image

急性失代偿性心力衰竭患者住院期间三尖瓣反流的动态演变。
目的:继发性三尖瓣反流(TR)与急性失代偿性心力衰竭(ADHF)的不良预后有关。然而,以前从未研究过三尖瓣反流随容量状态和治疗的动态演变。在这项研究中,我们试图探讨 ADHF 患者 TR 在院内的演变情况,并评估其对预后的影响:我们回顾性地纳入了因 ADHF 入院、院内超声心动图评估 TR≥2 次的患者。根据TR的演变情况,将患者分为持续性中度-重度TR、TR改善(从中度-重度到轻度-微小)和持续性轻度-微小TR。主要终点是5年全因死亡率和心力衰竭住院率(HFH)的综合。共纳入了 1054 名患者。在入院时患有中度重度TR的318名患者(30%)中,49%的患者TR严重程度有所改善,并显示出更好的去充血趋势,而那些持续患有中度重度TR的患者在入院和出院时具有更严重的心衰特征。心房颤动、既往心衰和入院前服用较多环形利尿剂与TR改善的概率较低有关。经调整后,与持续性中度-重度 TR 相比,改善 TR 与较低的 5 年全因死亡率/HFH 风险相关(危险比 [HR] 0.524,p = 0.008),与持续性轻微-轻度 TR 无差异(HR 0.878,p = 0.575)。二尖瓣反流的院内变化在所有亚组中结果一致:结论:在入院时患有中度-重度TR的ADHF患者中,49%的患者院内TR严重程度有所改善,这与5年全因死亡率和发病率风险的降低有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍: European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信